Amgen drug blocks immune chitchat that drives Sjögren’s disease As a CD40 ligand antagonist, dazodalibep blocks immune cell communication, potentially serving as the first drug to target the autoimmune disease’s cause.

https://www.drugdiscoverynews.com/amgen-drug-blocks-immune-chitchat-that-drives-sj-gren-s-disease-16235